CEO David Cordani is not convinced of the benefits of GLP-1s for weight-loss patients and said the US is the only country among developed nations where insurance coverage is being debated.

Cigna (CI) CEO David Cordani is not convinced of the benefits of GLP-1s for weight-loss patients and said the US is the only country among developed nations where insurance coverage is being debated.

For patient advocates and health economists, cases like Ekirch’s illustrate why prior authorization has become such a chronic ...

Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth. See why I rate CI stock a buy at current prices.

Dennison joined Cigna after serving as CFO at Nasdaq. Cigna Group CEO David Cordani said in a press release that the shift will allow the company to bring its insurance arm and Evernorth under one ...

Cigna has officially sealed the deal on the $ ... work that we have done for these customers," Cigna Group CEO David Cordani said in a press release. Cigna said that it plans to deploy the capital ...

and deliver even greater value for those we serve," said David M. Cordani, Chairman and Chief Executive Officer (CEO), The Cigna Group. "The bedrock of our continued success is our exceptional talent.

Ekirch said specialists have suggested that a series of infusions made from blood plasma called intravenous immunoglobulin -- ...